Cotización Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Acciones
REKA
IL0010810096
Farmacéuticos
Ventas 2021 | 264 M 72,03 M 66,76 M | Ventas 2022 | 292 M 79,8 M 73,96 M | Capitalización | 176 M 47,94 M 44,43 M |
---|---|---|---|---|---|
Resultado Neto 2021 | 6 M 1,64 M 1,52 M | Resultado Neto 2022 | -2 M -546 mil -506 mil | VE / Ventas 2021 | 1,56 x |
Deuda neta 2021 | 147 M 40,17 M 37,23 M | Deuda neta 2022 | 145 M 39,68 M 36,78 M | VE / Ventas 2022 | 1,1 x |
P/E ratio 2021 |
40,1
x | P/E ratio 2022 |
-85,5
x | Empleados | - |
Rendimiento 2021 |
3,73 % | Rendimiento 2022 |
-
| Flotante | 17,36 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chief Executive Officer | 80 | 24/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 01/11/18 |
Director/Board Member | 78 | 24/08/93 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 15/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 15/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 15/04/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+15,96 % | 70,86 mil M | |
+11,01 % | 27,37 mil M | |
-1,96 % | 8136,84 M | |
+1,91 % | 7923,73 M | |
-25,90 % | 7507,08 M | |
+1,40 % | 4648,54 M | |
+3,37 % | 4117,04 M | |
+13,69 % | 4082,77 M | |
-3,52 % | 3922,74 M |